Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Famotidine; Magnesium hydroxide; Calcium carbonate
Johnson & Johnson (Ireland) Limited
A02BA; A02BA53
Famotidine; Magnesium hydroxide; Calcium carbonate
10/165/800 milligram(s)
Chewable tablet
Product not subject to medical prescription
H2-receptor antagonists; famotidine, combinations
Marketed
2000-09-29
1 PACKAGE LEAFLET: INFORMATION FOR THE USER PEPCID DUO CHEWABLE TABLETS Famotidine 10mg, magnesium hydroxide 165mg, calcium carbonate 800mg READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 2 weeks. WHAT IS IN THIS LEAFLET? 1. What Pepcid Duo is and what it is used for 2. What you need to know before you take Pepcid Duo 3. How to take Pepcid Duo 4. Possible side effects 5. How to store Pepcid Duo 6. Contents of the pack and other information 1. WHAT PEPCID DUO IS AND WHAT IT IS USED FOR Pepcid Duo is used for the short-term treatment of the symptoms of heartburn and acid indigestion in adults and adolescents of 16 years & over. Pepcid Duo contains three active substances: • Famotidine is a medicine called a ‘H2 Antagonist (blocker)’. It reduces acid production in your stomach. • Magnesium hydroxide and calcium carbonate are ‘antacids’. They neutralise the acid in your stomach. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PEPCID DUO DO NOT TAKE PEPCID DUO: • if you are allergic to famotidine, magnesium hydroxide, calcium carbonate or any of the other ingredients of this medicine (listed in section 6) • if you have severe kidney problems • if you are allergic to other H2 Antagonist (medicines which controls the production of excess stomach acid) WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Pepcid Duo if you have: • Indigestion and have also lost weight involuntarily • Stomach pain which does not go away • Indigestion for the first time, or if your sym Read the complete document
Health Products Regulatory Authority 13 December 2023 CRN00DT7D Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pepcid Duo Chewable Tablets Famotidine 10mg Magnesium Hydroxide 165mg Calcium Carbonate 800mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains: Famotidine 10.00 mg Magnesium hydroxide 165.00 mg Calcium carbonate 800.00 mg Excipients with known effect: Lactose monohydrate (62.31 mg/tablet), glucose monohydrate (642.61 mg/tablet) and benzyl alcohol (0.000238 mg/tablet). Each tablet also contains maltodextrin (71.41mg/tablet) which contains glucose. For the full list of excipients, see section 6.1. Note: 165 mg of magnesium hydroxide means 69.3 mg of elemental magnesium and 800 mg of calcium carbonate means 320 mg of elemental calcium 3 PHARMACEUTICAL FORM Chewable tablet. Green coloured, mottled round chewable tablet with concave centre debossed with P. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pepcid Duo is indicated in short-term symptomatic treatment of heartburn and acid regurgitations in adults and adolescents 16 years & over. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology FOR ADULTS AND ADOLESCENTS (16 years & over). Chew one tablet thoroughly when symptoms occur, and swallow preferably with a glass of water. Do not exceed 2 tablets per day. Treatment duration is limited to 2 weeks (see section 4.4 Special warnings and Precautions for use). Paediatric population The safety and efficacy of Pepcid Duo in children under 16 years of age has not yet been established (no data are available). Elderly No dosage adjustment is required for the elderly. Renal Impairment This medicine is contraindicated in patients with severe renal failure (see section 4.3 Contraindications). Patients with renal impairment should consult their physician before taking famotidine/antacid combination (Please refer to section 4.4 Special warnings and precautions for use). Hepatic Impairment No dosage adjustment is required for famotidine/antacid combination in hep Read the complete document